BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19864527)

  • 1. Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.
    Jansen SA; Paunesku T; Fan X; Woloschak GE; Vogt S; Conzen SD; Krausz T; Newstead GM; Karczmar GS
    Radiology; 2009 Nov; 253(2):399-406. PubMed ID: 19864527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IV Administered Gadodiamide Enters the Lumen of the Prostatic Glands: X-Ray Fluorescence Microscopy Examination of a Mouse Model.
    Mustafi D; Gleber SC; Ward J; Dougherty U; Zamora M; Markiewicz E; Binder DC; Antic T; Vogt S; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2015 Sep; 205(3):W313-9. PubMed ID: 26295667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined application of pharamcokinetic DCE-MRI and IVIM-DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ.
    Tao WJ; Zhang HX; Zhang LM; Gao F; Huang W; Liu Y; Zhu Y; Bai GJ
    J Appl Clin Med Phys; 2019 Jul; 20(7):142-150. PubMed ID: 31124276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.
    Jansen SA; Conzen SD; Fan X; Krausz T; Zamora M; Foxley S; River J; Newstead GM; Karczmar GS
    Phys Med Biol; 2008 Oct; 53(19):5481-93. PubMed ID: 18780960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
    Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
    Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
    Boehm-Sturm P; Haeckel A; Hauptmann R; Mueller S; Kuhl CK; Schellenberger EA
    Radiology; 2018 Feb; 286(2):537-546. PubMed ID: 28880786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High resolution 3D MRI of mouse mammary glands with intra-ductal injection of contrast media.
    Markiewicz E; Fan X; Mustafi D; Zamora M; Roman BB; Jansen SA; Macleod K; Conzen SD; Karczmar GS
    Magn Reson Imaging; 2015 Jan; 33(1):161-5. PubMed ID: 25179139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
    Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
    Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology.
    Mustafi D; Zamora M; Fan X; Markiewicz E; Mueller J; Conzen SD; Karczmar GS
    NMR Biomed; 2015 Sep; 28(9):1078-86. PubMed ID: 26152557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer.
    Markiewicz E; Fan X; Mustafi D; Zamora M; Conzen SD; Karczmar GS
    Magn Reson Imaging; 2017 Jul; 40():48-52. PubMed ID: 28366759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
    Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
    Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ of the breasts: review of MR imaging features.
    Greenwood HI; Heller SL; Kim S; Sigmund EE; Shaylor SD; Moy L
    Radiographics; 2013 Oct; 33(6):1569-88. PubMed ID: 24108552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal Carcinoma in Situ: Quantitative Preoperative Breast MR Imaging Features Associated with Recurrence after Treatment.
    Luo J; Johnston BS; Kitsch AE; Hippe DS; Korde LA; Javid S; Lee JM; Peacock S; Lehman CD; Partridge SC; Rahbar H
    Radiology; 2017 Dec; 285(3):788-797. PubMed ID: 28914599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging.
    Consolino L; Longo DL; Dastrù W; Cutrin JC; Dettori D; Lanzardo S; Oliviero S; Cavallo F; Aime S
    Int J Cancer; 2016 Jul; 139(2):404-13. PubMed ID: 26941084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
    Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
    Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.